Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
PBPH
57
HOLDINGS
0%
ALSO IN PEPT
PEPT
28
HOLDINGS
nan%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus PEPT)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in PEPT |
Overlap | |
|---|---|---|---|---|
PBPH Overweight Relative to PEPT
| ELI LILLY & CO | 16.4% | |
| JOHNSON & JOHNSON | 9.4% | |
| ABBVIE INC | 7.3% | |
| MERCK & CO. INC. | 5.2% | |
| ASTRAZENECA PLC | 4.9% | |
| AMGEN INC | 4.4% | |
| NOVARTIS AG | 4.3% | |
| GILEAD SCIENCES INC | 4.1% | |
| PFIZER INC | 3.3% | |
| VERTEX PHARMACEUTICALS INC | 2.7% |
PBPH Underweight Relative to PEPT
| BIOMARIN PHARMACEUTICAL INC | 0.2% | |
| BRIDGEBIO PHARMA, INC. | 0.2% | |
| ELANCO ANIMAL HEALTH, INC. | 0.2% | |
| GALDERMA GROUP AG | 0.3% | |
| SHIONOGI & CO LTD | 0.3% | |
| ROCHE HOLDING AG-BR | 0.3% | |
| JAZZ PHARMACEUTICALS PLC | 0.3% | |
| NEUROCRINE BIOSCIENCES INC | 0.3% | |
| ROIVANT SCIENCES LTD. | 0.3% | |
| EXELIXIS INC | 0.3% |